CMPI
NASDAQ:CMPI
Checkmate Pharmaceuticals, Inc.
- Stock
locale
United States
market
STOCKSindustry
Biotechnologywebsite
www.checkmatepharma.comipo date
Aug 07, 2020
Checkmate Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing novel therapeutics for the treatment of cancer. It develops CMP-001, which is in phase II clinical trial in combination with pembrolizumab to treat patients with PD-1 refractory melanoma; combination with nivolumab to treat patients with PD-1 naïve neoadjuvant mela...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus